A nurse is caring for a client who has schizophrenia and is taking an antipsychotic medication. Which of the following screening tools should the nurse use to identify tardive dyskinesia?

A. Abnormal Involuntary Movement Scale. The Abnormal Involuntary Movement Scale (AIMS) is a validated tool specifically designed to assess and identify tardive dyskinesia in clients taking antipsychotic medications. The AIMS evaluates the presence, frequency, and severity of involuntary movements, providing a structured approach for monitoring and documenting these symptoms over time. B. Brief Psychiatric Rating Scale. The Brief Psychiatric Rating Scale (BPRS) is utilized to assess a range of psychiatric symptoms, including depression, anxiety, and psychosis. However, it does not specifically address the assessment of abnormal involuntary movements associated with tardive dyskinesia. Therefore, while it is useful for general psychiatric evaluation, it is not appropriate for identifying tardive dyskinesia. C. Patient Health Questionnaire-9. The Patient Health Questionnaire-9 (PHQ-9) is a widely used screening tool for assessing the severity of depression. It focuses on mood-related symptoms and does not evaluate movement disorders or side effects of antipsychotic medications. As such, it is not relevant for identifying tardive dyskinesia. D. Mental Status Examination. The Mental Status Examination (MSE) provides a comprehensive assessment of a client’s cognitive and emotional state, covering areas such as appearance, behavior, thought processes, and mood. While the MSE is valuable for overall psychiatric evaluation, it does not specifically assess for tardive dyskinesia or abnormal involuntary movements, making it unsuitable for this purpose.